Fiber Use in Pediatric Short Bowel Syndrome
NCT00922805 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2014-01-15
Summary
Short bowel syndrome (SBS) is a form of disease that results from removal of a significant portion of the intestine leading to poor nutrient absorption. Infants with short bowel syndrome suffer from diarrhea and poor growth. The care of these infants is limited by the lack of effective therapies.
Soluble fiber (guar gum) is an indigestible form of sugar that is mostly contained in fruits and vegetables. Soluble fiber can reduce the severity and duration of persistent (constant) diarrhea in children.
The purpose of this research study is to evaluate the many effects of fiber added in the diet of infants with SBS
Conditions
- Short Bowel Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
guar gum
guar gum (20 g/l of formula) for one week
Sponsors & Collaborators
-
USDA Grand Forks Human Nutrition Research Center
collaborator FED -
Baylor College of Medicine
collaborator OTHER -
Arkansas Children's Hospital Research Institute
lead OTHER
Principal Investigators
-
Juliana C Frem, MD · University of Arkansas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 2 Weeks
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Infant Formula for Preterm Infants
NCT00658905 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 1)
NCT07303738 ·Status: RECRUITING ·Phase: PHASE4
-
Infant & Toddler Short Gut Feeding Outcomes Study
NCT01946503 ·Status: COMPLETED
-
The Use of High Bile-Binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 3)
NCT06913621 ·Status: NOT_YET_RECRUITING
-
Neokare Safety and Tolerability Assessment in Neonates With GI Problems
NCT05293353 ·Status: UNKNOWN
-
Feeding Tolerance and Gut Maturation of Infants Consuming a Formula Rich in Glycoprotein
NCT04880083 ·Status: COMPLETED ·Phase: NA
-
Prebiotic in Preventing Low Birth Weight
NCT02721225 ·Status: COMPLETED ·Phase: NA
-
Early Provision of Enteral Microlipid and Fish Oil to Infants With Enterostomy
NCT01306838 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)
NCT04516213 ·Status: COMPLETED ·Phase: NA
-
Feeding Bovine Colostrum to Preterm Infants
NCT02054091 ·Status: COMPLETED ·Phase: NA
-
Effect of Formula on Infant Behavior
NCT02746016 ·Status: COMPLETED ·Phase: NA
-
Bovine Colostrum for Preterm Newborns
NCT03085277 ·Status: COMPLETED ·Phase: NA
-
Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA
NCT05904626 ·Status: RECRUITING ·Phase: PHASE2
-
Growing Up Formula Versus Nutritional Supplements: Effect on Catch up Growth, Micronutrient Status, and Solid Foods Intake in Toddlers With Mild or Moderate Malnutrition
NCT05088590 ·Status: COMPLETED ·Phase: NA
-
Study of Early Infant Diet on Growth and Development
NCT00616395 ·Status: COMPLETED
-
Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying
NCT01956682 ·Status: COMPLETED ·Phase: PHASE4
-
Prebiotics and Microbiota Composition and Functionality in Rural Burkinabe Infants
NCT02716935 ·Status: COMPLETED ·Phase: NA
-
Addition to Infant Formula of 2-fucosyllactose (2-FL)
NCT03109223 ·Status: COMPLETED ·Phase: NA
-
The Impact of Commercial Blenderized Formula on Caloric Needs, Gastrointestinal Symptoms, and Gut Microbiome in Children With Cerebral Palsy (CP)
NCT06488560 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Influences of High-fiber, Organic Whole-food Formula on the Gut Microbiome in Critically Ill Children
NCT03414775 ·Status: COMPLETED ·Phase: NA
-
Evaluation of PKU Explore France
NCT04898829 ·Status: COMPLETED ·Phase: NA
-
Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula
NCT04934397 ·Status: TERMINATED ·Phase: NA
-
Feeding Intolerance in Formula-Fed Infants
NCT02028156 ·Status: TERMINATED ·Phase: NA
-
GMP Case Studies of Tolerance, Safety and Acceptability in PKU and TYR
NCT05062226 ·Status: COMPLETED ·Phase: NA
-
Effects of Complementary Feeding on Infant Growth and Gut Health
NCT05012930 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA